Oral Contraceptives Are a Risk Factor for Cerebral Vein Thrombosis

Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.

Thromb Haemost 1996; 76(03): 477-478
DOI: 10.1055/s-0038-1650604

Letters to the Editor

Schattauer GmbH Stuttgart

Autoren

I Martinelli

¹The Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Maggiore Hospital and University of Milan, Italy
F R Rosendaal

²The Dept of Clinical Epidemiology, Leiden University Hospital, Leiden, The Netherlands
J P Vandenbroucke

²The Dept of Clinical Epidemiology, Leiden University Hospital, Leiden, The Netherlands
P M Mannucci

¹The Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Maggiore Hospital and University of Milan, Italy

Received 29. Mai 1996

Accepted 30. Mai 1996

Publikationsdatum:
10. Juli 2018 (online)

References
1 Martinelli I, Landi G, Merati G, Celia E, Tosetto A, Mannucci PM. Factor V gene mutation is a risk factor for cerebral vein thrombosis. Thromb Haemost 1996; 75: 393-394

Thieme Connect PubMed Suche in Google Scholar
Download RIS citation
2 Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaalb FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453-1457

Crossref PubMed Suche in Google Scholar
Download RIS citation
3 Rosendaal FR. Oral contraceptives and screening for factor V Leiden. Thromb Haemost 1996; 75: 524-525

Thieme Connect PubMed Suche in Google Scholar
Download RIS citation